Germline mutations of the Brca1 gene are responsible for most cases of familial breast and ovarian cancers, but somatic mutations are rarely detected in sporadic events. Moreover, mouse embryos de®cient for Brca1 have been shown to die during early embryogenesis due to a proliferation defect. These ®ndings seem incompatible with the tumor suppress function assigned to this gene and raise questions about the mechanism by which Brca1 mutations cause tumorigenesis. We now directly demonstrate that BRCA1 is responsible for the integrity of the genome. Murine embryos carrying a Brca1 null mutation are developmentally retarded and hypersensitive to girradiation, suggesting a failure in DNA damage repair. This notion is supported by spectral karyotyping (SKY) of metaphase chromosomes, which display numerical and structural aberrations. However, massive chromosomal abnormalities are only observed when a p53 7/7 background is introduced. Thus, a p53 dependent cell cycle checkpoint arrests the mutant embryos and prevents the accumulation of damaged DNA. Brca1 7/7 ®broblasts are not viable, nor are Brca1 7/7 : p53 7/7 ®broblasts. However, proliferative foci arise from Brca1 7/7 : p53 7/7 cells, probably due to additional mutations that are a consequence of the accumulating DNA damage. We believe that the increased incidence of such additional mutations accounts for the mechanism of tumorigenesis associated with Brca1 mutations in humans.
Introduction
Breast cancer is the most common cancer and the second leading cause of cancer mortality in women (Alberg and Helzlsouer, 1997; Hill et al., 1997) . About 3 ± 5% of the breast cancer cases are believed to be heritable (Hill et al., 1997) . Two cancer susceptibility genes, Brca1 and Brca2 (Wooster et al., 1995) have been discovered. Mutations in the Brca1 and Brca2 genes represent most cases of hereditary breast cancers (Casey, 1997) , and mutations in Brca1 were also found to be related to an increased risk for other cancers (Casey, 1997) .
The human Brca1 gene encodes a nuclear protein of 1863 amino acids which was recently shown to colocalize and co-immunoprecipitate with RAD 51, a homolog of E. Coli RecA that is involved in DNA damage repair (Muris et al., 1993; Scully et al., 1997a,b; Shinohara et al., 1993 Shinohara et al., , 1992 . Upon treatment with reagents that damage DNA, BRCA1 becomes phosphorylated and relocates to intranuclear structures in which DNA replication is taking place (Scully et al., 1997a) . While these ®ndings suggest an involvement of BRCA1 in DNA damage repair, the function of BRCA1 in mediating genomic stability has not been illustrated.
The mouse Brca1 gene encodes a protein of 1812 amino acids with about 58% identity to the human protein. The function of murine Brca1 has been studied by targeted gene disruptions in embryonic stem (ES) cells followed by germline transmission. It was shown that mice that were heterozygous for the targeted mutations were normal whereas the homozygotes died between embryonic day 6-13.5 (E6-13.5) (Gowen et al., 1996; Hakem et al., 1996; Liu et al., 1996) . In most cases, the mutations of BRCA1 are associated with a severe developmental delay and a cellular proliferation defect (Hakem et al., 1996; Liu et al., 1996; Ludwig et al., 1997) . It was recently shown that the early lethality of BRCA1 7/7 embryos could be partially rescued by a p53-null or p21-null mutation, suggesting that loss of BRCA1 may trigger the activation of a cell cycle checkpoint (Hakem et al., 1997; Ludwig et al., 1997) . However, the mechanism that causes such an activation has not been demonstrated.
In the present study, we have directly demonstrated that murine BRCA1 is responsible for genomic integrity as Brca1 7/7 embryos exhibited hypersensitivity to g-irradiation and chromosomal abnormalities. We also found that the loss of p53 is not itself sucient to allow for the growth of Brca1 7/7 embryonic ®broblast cells. It does, however, cause the formation of proliferative foci, probably due to additional mutations that are a consequence of the accumulating DNA damage. We postulate that the same sort of DNA damage may result from the loss of BRCA1 in vivo and lead to tumor formation, and that this could be a more general model for related tumor suppressor systems.
Results
Targeting construct and abnormality of Brca1 mutant mice pBrca1neo ( Figure 1a ) was used to disrupt exon 11 which encodes about 60% of the amino acids of murine BRCA1 (Bennett et al., 1995; Lane et al., 1995) . Homologous recombination between the targeting construct and the endogenous counterpart would delete 330 bp of intron 10 and 407 bp of exon 11, including a splice acceptor for exon 11. A previous investigation showed that embryos carrying a similar deletion of this exon (330 bp of intron 10 plus 1.5 kb of exon 11) died at E9.5-13.5 (Gowen et al., 1996) . However, as summarized in Table 1 , our Brca1 mutant embryos (referred to as Brca1 117/7 ) died at E7.5-9.5 and exhibited abnormalities substantially dierent from those described previously (Gowen et al., 1996) .
To assess the Brca1 , and Brca1 +/+ embryos were present in a ratio of 1 : 2 : 1, and Brca1 117/7 embryos did not display apparent abnormalities (Table 1) . However, at E7.5, Brca1 117/7 embryos (n=11) were found to be much smaller than their littermate controls (Brca1 11+/7 and Brca1 11+/+ embryos) and looked like E6.5 embryos, suggesting that they were developmentally arrested at this stage (Figure 2a ). At E8.5, about 1/3 of the Brca1 117/7 embryos were found dead. The others remained very small, resembling those found in E7.5 litters ( Figure  2b ). In histological sections, extraembryonic structures, such as the visceral yolk sac, and ectoplacental and exocoelomic cavities were signi®cantly developed whereas embryonic portions lagged behind (Figure 2g ). At E9.5, over half of Brca1 117/7 embryos were dying or dead. The remainder were abnormal and much smaller compared with the controls, indicating that the development of these embryos was severely aected (Figure 2c ± e) . A small portion (about 5%) of the Brca1 117/7 embryos were able to form non-axial mesodermal tissues, such as allantois, amnion, yolk sac and blood cells (Figure 2d and not shown). They could also form headfold-like structures, as revealed by expression of the Otx-2 gene, a forebrain and midbrain marker (Figure 2k ), although these embryos were abnormal. Whole mount in situ Figure 1 Targeted disruption of Brca1 gene. (a) Targeting vector pBrca1neo contains a 9 kb Brca1 genomic sequence with a pGKneo cassette (Tybulewicz et al., 1991) , that deletes a 0.74 kb XhoI ± EcoRI segment. As, Asp 718; Ec, EcoRI; Ev, EcoRV; Xh, XhoI. (b) Southern blot analysis of DNAs isolated from a representative litter of pups generated by intercrosses between Brca1 11+/7 mice. DNAs were digested by EcoRV and hybridized with the 3'¯anking probe. The wild type (11.3 kb) and mutant (9 kb) fragments were as indicated. (c) PCR genotyping of a representative litter of E8.5. All abnormal embryos were homozygous for the targeted mutation embryos (arrow) appeared similar to E7.5 Brca1 117/7 embryos except for the increased size of the extraembryonic portions. All ®ve control embryos shown in (a and b) were either heterozygous or wild type for Brca1 11 mutation. Arrowheads point to their headfolds. (c ± e) E9.5 embryos. Most mutant embryos were very small; (c) arrowhead points to embryonic portion compared with their littermates; (e) arrow points to the head. About 5% of the mutants (d) formed a headfold-like structure (arrow), allantois (arrowhead) and yolk sac. (f and g) Histological sections of E8.5 embryos. Neural tube (nt) and heart (ht) of control embryo (f) were clearly visible. The embryonic portion of mutant embryos (arrow in g) remained very small. The visceral yolk sac, and exocoelomic cavity are labeled by an arrowhead and an asterisk respectively. (h) and (i) Brachyury expression in control and mutant embryos. Primitive streak of the E7 (left arrow), notochord of E8.5 (middle arrow) and tail bud of E9.5 (black arrow) of control embryos are shown in (h). Three E9.5 mutant embryos are shown in (i). Domains that express the Brachyury are pointed to by arrows. (j and k) Otx-2 expression in wild type (j) and mutant embryos (k) is indicated by arrows. Arrowhead in (k) points to allantois. White and black bars are 200 mm and 100 mm, respectively Brca1 117/7 embryos are sensitive to g-irradiation It is known that BRCA1 and Rad51, a homolog of E. coli RecA that is involved in DNA damage repair (Muris et al., 1993; Shinohara et al., 1992 Shinohara et al., , 1993 , colocalize in the cell nucleus and interact with each other (Scully et al., 1997b) . Since Rad51 7/7 embryos were hypersensitive to g-irradiation (Lim and Hasty, 1996) , we predicted that Brca1 117/7 embryos might have a similar phenotype if these two genes interact in vivo. To test this, blastocysts were isolated from Brca1 11+/7 intercrosses and subjected to g-irradiation with unirradiated embryos as controls. After treatment, both irradiated and unirradiated blastocysts were incubated in growth medium for up to 7 days. Without irradiation, cultured blastocysts of homozygous (n=13) and control (n=35) embryos showed no apparent dierences in the outgrowth of trophoblast cells (TCs) (Figure 3a , b). However, a dramatic dierence in the outgrowth of the inner cell mass (ICM) was observed between control and homozygotes (Figure 3a, b) . As control ICMs increased in size signi®cantly (Figure 3b ), mutant ICMs remained very small ( Figure 3a ). It has been suggested that the TCs can survive because they are in a relatively quiescent state and can undergo DNA endo-duplication, allowing them to tolerate spontaneous DNA damage (Lim and Hasty, 1996) . However, after receiving irradiation at 300 rads, the growth of mutant TCs (n=10) was dramatically reduced, from 20 ± 30 cells/embryo to 5 ± 10 cells/embryo (Figure 3c ), while control TCs (n=25) were only slightly reduced, from an 20 ± 35 cells/embryo to 20 ± 25 cells/embryo (Figure 3d ).
Brca1
117/7 embryos show chromosomal instability
The hypersensitivity of Brca1 117/7 cells to g-irradiation provided compelling evidence that BRCA1 is involved in DNA double-strand break repair (Ritter et al., 1977) . If this is the case, gross chromosomal changes should be observable in Brca1
embryos. The chromosome number and karyotype of Brca1 7/7 embryos were therefore analysed. Examination of E7.5 control embryos indicated that over 97% of the cells contained 40 chromosomes (Table 2 ). In Brca1 117/7 embryos, about 70% of the cells maintained the normal chromosome number, and the remainder showed chromosomal abnormalities, containing less or more than 40 chromosomes per cell The chromosomal abnormalities are dramatically increased in a p53-null background It was shown recently that the early lethality of BRCA1 7/7 embryos could be partially rescued by a p53-null or p21-null mutation (Hakem et al., 1997; Ludwig et al., 1997) . Since p53 is known to regulate the cell cycle through p21 (el-Deiry et al., 1993; Harper et al., 1993) we postulated that the rescue could be due to a failure in checkpoint control caused by the loss of these genes. If this is the case, a p53-null background should be more tolerant to the genetic instability in BRCA1 7/7 cells and allow accumulation of mutations and DNA damage. To test this, we crossed p53-null mice (Donehower et al., 1992) with the Brca1 11+/7 mice and analysed the resulting Brca1 117/7 : p53 7/7 embryos. In the p53-null background, the Brca1 117/7 embryos survived on the average of 2 days longer, indicating that loss of p53 could partially rescue the BRCA1 de®ciency. At E9.5, all Brca1 117/7 : p53 7/7 were smaller and morphologically abnormal compared with their littermates (Figure 4a, b) . At E10.5, all double homozygous mutants were dying and partially deteriorated (not shown). We then prepared chromosome spreads from E9. embryos displayed massive abnormalities. Of 76 metaphase spreads examined, 22 (29%) contained more than 40 chromosomes, and 33 (43%) contained less than 40 chromosomes (Table 2) . We wished to determine whether the embryonic cell metaphases contained structural abnormalities in addition to numerical changes. The chromosome spreads were subjected to spectral karyotyping (SKY), a recently developed molecular cytogenetic technique in which each chromosome is painted a dierent color by hybridization to¯uorescent probes (Schrck et al., 1996) . SKY allows an unambiguous identi®cation of each chromosome, an extremely dicult task in early embryos by G-or DAPIbanding.
No structural aberrations were observed in metaphases from Brca1 +/+ : p53 7/7 and Brca1 11+/7 : p53 7/7 embryos (not shown). In contrast, chromosomal rearrangements, including translocations and dicenteric chromosomes, were found in Loss of p53 is not sucient for Brca1 7/7 cells to proliferate
The above data show that the loss of p53 partially rescued the BRCA1 de®ciency at the expense of genomic integrity. It is conceivable that accumulating DNA damage could lead to the inactivation of genes that are essential for embryonic growth and patterning, leading to the death of Brca1 117/7 : p53 7/7 embryos. However, it is not clear that the loss of p53 could rescue the BRCA1 de®ciency at the cellular level. To address this, we derived mouse embryonic ®broblast cells (MEFs) from 5 E9.5 Brca1 7/7 : p53 7/7 and 14 control embryos (including those wild type for both genes). While all control MEFs grew vigorously and formed con¯uent monolayers quickly (Figure 4c ), all ®ve Brca1 117/7 : p53 7/7 MEFs proliferated poorly at the primary passage. A majority of Brca1 117/7 : p53 7/7 cells had enlarged cytoplasm and entered quiescent status (Figure 4d ). With time, multiple foci were observed from all ®ve cultured double mutant MEFs (Figure 4e , f). In the subsequent passages, three of Brca1 and Brca1 117/7 : p53 +/+ embryos (n=6) and found that the mutant cells could not grow even at the primary passage. Altogether, these data indicated that inactivation of p53 cell cycle control does not overcome the phenotypes. (a and b) E9.5 Brca1 117/7 : p53 7/7 and control embryos. Both Brca1 117/7 : p53 7/7 embryos (right embryo in a, b) were smaller than their control (left in a), and showed signs of deterioration. (c and f), Morphology of Brca1 117/7 : p53 7/7 and control MEFs. All control MEFs (n=14) reached high density 3 days after plating (c), whereas Brca1 117/7 : p53 7/7 MEFs (d) failed to grow and displayed enlarged cytoplasm with (left arrow) or without (right arrow) extensive vacuolization. Multiple foci were apparent from Brca1 117/7 : p537/7 MEFs after 10 days in culture (e). An enlarged view of (e) was shown in (f). Bars are 100 mm cellular defect caused by the loss of BRCA1. However, it does extend the survival of the Brca1 117/7 cells and allows further alteration to occur, which may eventually lead to malignant transformation.
Discussion
Previous investigations showed that targeted disruptions of the murine Brca1 gene result in embryonic lethality from E6-13.5, depending on the site at which the mutation is introduced. Embryos homozygous for deletion of exon 2 (Ludwig et al., 1997) , exons 5 ± 6 (Hakem et al., 1996) or a deletion of a 184 bp EcoRI fragment within the 5' portion of exon 11 (Liu et al., 1996) exhibited cellular proliferation defects and died before E8. In contrast, embryos carrying a deletion of a 1.8 kb XhoI ± KpnI genomic fragment that contains 330 bp of intron 10 and 1.5 kb of exon 11 died at E9.5 ± 13.5, displaying signs of both rapid proliferation and excessive cell death within the neural tube (Gowen et al., 1996) . Although the molecular basis for this discrepancy is unknown, it is conceivable that the removal of a splice acceptor site in the latter case may generate dierent splicing variants of Brca1 that rescue the early post-implantation embryonic defects uncovered by the other studies (Ludwig et al., 1997; Hakem et al., 1996; Liu et al., 1996) . In the present study, our targeting construct deletes a 0.74 kb XhoI ± EcoRI ± EcoRI segment containing the same exon 11 splice acceptor that was deleted previously (Gowen et al., 1996) . However, the Brca1 117/7 embryos displayed abnormalities that are much more severe than those reported by Gowen et al. (1996) . Because we also used the same strain background as Gowen et al. (1996) , we believe that the genetic background is not the cause of the discrepancy. Notably, the phenotype of Brca1 117/7 embryos is similar to, but milder than those reported by the other studies (Ludwig et al., 1997; Hakem et al., 1996; Liu et al., 1996) . It was shown previously that deletion of exons 5 and 6 of the Brca1 gene resulted in a dramatic increase in p21 transcription (Hakem et al., 1997) . However, we did not detect any obvious change in the p21 protein level in E6.5 Brca1 117/7 embryos by immunohistochemistry (not shown). While this discrepancy needs to be resolved by further study, it suggests that the targeted disruption of dierent domains of BRCA1 may cause a dierential response of its downstream genes.
It has been speculated that BRCA1 is involved in DNA damage repair. The ®rst hint of such a function of BRCA1 came from the observation that it colocalizes and co-immunoprecipitates with RAD51 (Scully et al., 1997b) . It was also shown that in response to treatment with DNA damaging reagents, BRCA1 became hyperphosphorylated and relocated along with RAD51 to intranuclear structures where DNA replication was taking place (Scully et al., 1997a) . RAD51 is involved in ATP-dependent DNA strand exchange reactions and is known to be a homolog of yeast RecA, which functions in homologous recombination and DNA damage repair . We now provide additional evidence to support a role of BRCA1 in DNA damage repair by directly demonstrating that a loss-of-function mutation of BRCA1 results in chromosomal abnormalities, including numerical and structural changes. It was shown that the most common damage caused by ionizing irradiation is double-strand breaks (DSB) of DNA (Ritter et al., 1977) . Thus, the hypersensitivity of Brca1 117/7 blastocysts to g-irradiation may suggest a role of BRCA1 in the DSB repair.
Notably, another breast tumor suppressor gene, Brca2 exhibits many similarities to the Brca1 gene. Like BRCA1, BRCA2 also co-localizes with RAD51 (Sharan et al., 1997) . BRCA2-null embryos are also hypersensitive to g-irradiation and exhibit early embryonic lethality, which is partially rescued by a p53 mutation (Ludwig et al., 1997) . Moreover, embryos carrying hypomorphic alleles of BRCA2 exhibit chromosomal abnormalities similar to those seen in Brca1 117/7 and RAD51 7/7 embryos (Patel et al., 1998) . The striking similarities between BRCA1 and BRCA2 suggest that these two proteins function in the same DNA repair process in which RAD51 is involved.
Despite the similarities, these two genes also exhibit dierences. For example, BRCA2 has eight BRC motifs clustered in exon 11 (Wong et al., 1997) , which are lacking in BRCA1. The BRC motifs are conserved in BRCA2 proteins of dierent mammals from mice to human (Bignell et al., 1997) , suggesting that this domain is important for its function. Instead of BRC motifs, a conserved C-terminal domain of human and mouse BRCA1 proteins (BRCT) is also found in many nonorthologous proteins including 53BP1, RAD9, XRCC1 and others. Proteins with BRCT domain comprise a superfamily, and all of them appear involved in DNA damage responsive checkpoints (Bork et al., 1997) . In addition to a BRCT domain, a ring zinc ®nger found at the N-terminal of human and mouse BRCA1 suggests it has the ability to bind to DNA (Bienstock et al., 1996) or another protein (Mackay and Crossley, 1998) . Neither the BRCT domain nor the zinc ®nger have been found in BRCA2. These dierences argue that BRCA1 and BRCA2 may have distinct functions in developmental processes.
Our data showed that Brca1 117/7 embryos exhibited both early post-implantation growth retardation and chromosomal abnormalities. Mouse embryos at early post-implantation stages undergo rapid cell proliferation with the epiblast cells increasing from 120 cells per E5.5 embryos to 660 cells per E6.5 embryos. The cell number increases further to 14290 per E7.5 embryo (Snow, 1977) . Thus, we have considered a hypothesis that BRCA1 functions as a stimulus for embryonic cell proliferation. However, such a hypothesis could not explain the hypersensitivity to g-irriadiation and chromosomal abnormalities of the Brca1 117/7 embryos. Moreover, the early post-implantation growth retardation is rescued in a p53-null background, at the expense of a dramatic increase in chromosomal abnormalities. Altogether, these data indicate that the growth defect of Brca1 117/7 embryos is secondary to the observed genetic instability. p53 has been shown to be essential for the integrity of the genome (el-Deiry, 1998; Vogelstein and Kinzler, 1992) . Upon treatment of reagents that damage DNA, p53 protein levels increase. Its C-terminal domain bind directly to the damaged DNA, allowing repair processes to initiate (Bakalkin et al., 1994 (Bakalkin et al., , 1995 . p53 also activates its target genes such as p21, a CDK inhibitor, to prevent cells that contain damaged DNA from proliferating el-Deiry et al., 1993 el-Deiry et al., , 1994 Harper et al., 1993; Waga et al., 1994) . However, if the damage is too extensive to be repaired, p53 triggers expression of proteins that promote apoptosis, such as Bax, to eliminate the cells that contain the damage (Miyashita and Reed, 1995) . Based on our analysis of the Brca1 117/7 embryos, we propose that BRCA1 plays a indispensable role in the DNA repair machinery in concert with RAD51. In the normal situation, the embryonic cells can eciently repair spontaneous DNA damage associated with the rapid proliferation of the early post-implantation embryos. The loss of BRCA1 in these cells results in genetic instability, triggering a p53 mediated cell cycle checkpoint, which restrains the cells from proliferating and prevents accumulation of un-repaired DNA. This checkpoint is abolished in Brca1 117/7 : p53
embryos, allowing accumulation of massive chromosomal abnormalities.
In summary, we showed that Brca1 117/7 embryos were hypersensitive to g-irradiation and displayed massive abnormalities in chromosome number and structure when they were placed on a p53-null background. These ®ndings directly illustrate the role of BRCA1 in maintaining the stability of the genome and provide some insights regarding the mechanism by which BRCA1 suppresses tumor formation. Notably, tumorigenesis in people with BRCA1 mutations occurs with relatively long latency and somatic mutations are rarely detected in sporadic cases (Easton, 1997; Futreal et al., 1994; Struewing et al., 1997; Xu and Solomon, 1996) . In light of our ®ndings, we believe that this is primarily because the loss of BRCA1 does not directly promote tumorigenesis. Our observation that the inactivation of p53 itself is not sucient to allow BRCA1 cells to proliferate but does cause formation of multiple proliferative foci suggests a involvement of multiple factors in the BRCA1 associated tumorigenesis. This may account for the relatively long latency of cancer incidence in people carrying Brca1 mutations and the rare incidence of somatic Brca1 mutations in sporadic cancers (Easton, 1997; Futreal et al., 1994; Struewing et al., 1997; Xu and Solomon, 1996) .
Materials and methods

Targeting vector
Recombinant phages containing genomic DNA of the Brca1 locus were isolated from a 129 mouse library (Stratagene). To construct the targeting vector for Brca1 , a 6 kb EcoRI ± XhoI fragment that is 5' to exon 11 of the Brca1 gene was subcloned into the XbaI and EcoRI sites of pPNT (Tybulewicz et al., 1991) The resulting construct was cleaved with XhoI and NotI, followed by insertion of a 3 kb EcoRI ± NotI fragment (the NotI site is from the polylinker of the phage vector). The ®nished construct, pBrca1neo, is shown in Figure 1a .
Homologous recombination in ES cells and generation of germline chimeras TC1 ES cells (Deng et al., 1996) were transfected with NotI digested pBrca1neo and selected with G418 and FIAU. The culture, electroporation, and selection of TC1 cells was carried out as described . Genomic DNAs from G418 r /FIAU r clones and the parental TC1 cell line were digested with Asp718 and then probed with a 5' fragment, or digested with EcoRV and probed with a 3' probe. The 5' probe is a 1.2 kb EcoRI fragment and the 3' fragment is a 1 kb EcoRI ± XhoI fragment. Of 156 of G418 and FIAU doubleresistant ES clones analysed for homologous recombination, 18 contained correct targeting events. Germline transmission was obtained from injection of three ES clones into C57BL/6J blastocysts.
Mating and genotyping mice
Chimeric mice were mated with NIH Black Swiss females (Taconic), C57B6 or 129SvEv. Agouti ospring were tested for the presence of the Brca1 allele by Southern analysis or PCR. For PCR analysis, the wild type Brca1 allele was detected by using a 5' oligonucleotide (5'-CAAA-CAGCCTGGCATAGCAG-3') and a 3' oligonucleotide (5'-GATGAAGTCCTCAGGTTGAAG-3'). This primer pair¯anks the PGKneo insertion site, and ampli®es a 618 bp fragment from the wild type Brca1 gene. DNA was also ampli®ed using the 3' primer and a primer speci®c to PGKneo (5'-CCAGACTGCCTTGGGAAAAGC-3'). In this case, a fragment of about 730 bp is detected in mice heterozygous or homozygous for the Brca1 11 allele, while no signal can be detected in wild type mice. p53-de®cient mice (Donehower et al., 1992) were mated with Brca1
to generate Brca1 11+/7 : p53
mice which were then interbred to generate Brca1 117/7 : p53 7/7 embryos.
In vitro culture and irradiation of blastocysts
Conditions for blastocyst culture were as described (Deng et al., 1994) . On day 0, blastocysts were either irradiated by a g-generator at a dose of 300 rads or 0 rad (untreated) before the initiation of the culture. The blastocysts of both groups were subsequently transferred individually into each well of 24-well culture plates containing growth medium. Photographs of cultured embryos were taken from day 3 through day 7 at the same magni®cation. Cells were harvested and DNAs were extracted for genotype analysis by PCR on day 7. The number of trophoblast-like cells (TCs) were counted and the area of inner cell mass (ICM) was measured by NIH image. The data were examined by Student's t-test. backgrounds died before E9.5, we derived Brca1 117/7 : p53 +/+ and control cells at E8.5. Individual embryo was trypsinized at room temperature for 10 min and plated into one well of 12-well (for E9.5 embryos) or 24-well (for E8.5 embryos) plates. MEFs from all control embryos ®lled the well quickly and were passed into a larger well at each subsequent passage. Foci from Brca1 117/7 : p53 7/7 cells were generally passed into wells of same size (24-well plate) in the subsequent passages. Only in two cases, the Brca1 117/7 : p53 7/7 cells reached about 70% con¯uence and they were passed into 12-well plates.
Chromosome preparations from and spectral karyotyping of mouse embryos
Chromsomes of mouse embryos were prepared following the approach described by EP Evans (1987) with minor modi®cations. The E.7.5 ± E.9.5 embryos were dissected and cultured in complete medium with 0.1 mg/ml Colcemid (Sigma) for 8 h at 378C . The embryos were treated with 1% tri-sodium citrate for 20 min and then ®xed with 3 : 1 mixture of methanol : acetic acid. The embryos were then processed as described.
Spectral karyotyping of the embryonic cell metaphases was performed as described previously for human and mouse (SchroÈ ck et al., 1996; Liyanage et al., 1996) . Brie¯y,¯ow-sorted mouse chromosomes were ampli®ed by degenerate oligonucleotide-primed PCR incorporating haptenized or uorochrome-conjugated nucleotides (Telenius et al., 1992) . The degenerate primer sequence used was: 5'-CGGACTC-GAGNNNNNNTACACC-3'. The resulting chromosomespeci®c painting probes were hybridized to the metaphase chromosomes (described above) on glass slides for 2 ± 3 days, in the presence of a large excess of unlabeled Cot-1 fraction of mouse genomic DNA (kindly provided by M Liyanage). Slides were washed in 50% formamide/16SSC to detect nucleotides directly labeled with Rhodamine 110 (Applied Biosystems), Spectrum Orange (Vysis) and Texas Red (Molecular Probes); additionally, biotin and digoxigenin indirectly-labeled nucleotides were detected with Cy5 and Cy5.5 conjugates (Amersham), respectively. Chromosomes were counterstained with DAPI. Spectral analysis of chromosomes was carried out on a microscope (Leica DMRBE) that was equipped with a SD200 spectral cube (Applied Spectral Imaging) and a custom-designed ®lter cube (Chroma Technology) that allows for the simultaneous excitation of all dyes and the measurement of their emission spectra. Analysis of the images was performed using SkyView software (Applied Spectral Imaging). To visualize the raw spectral image, dierent colors (blue, green, or red) were assigned to speci®c spectral ranges. Chromosomes then were unambiguously identi®ed using a spectral classi®cation algorithm that results in the assignment of a separate classi®cation color to all pixels with identical spectra.
